Skip to content

Mira Pharmaceuticals, Inc.

MIRA· NasdaqCore metricsCIK 1904286

Pharmaceutical preparations552 peers

Last sale
Nov 6, 2026 · +0.89%
Market cap
$23.32M
42.02M shares
Filings
200
—
—
—
-$1.21M
Q2 2026N/M FY25 yoy
—
—
—
—
—
—
-$0.03
Q2 2026N/M FY25 yoy
$3.61M
Q2 2026+124.0% FY25 yoy
$23.32M
—
—
3.4×
—
—

FY2025 figures · derived

Price

$0.55563.49%$0.965past year
Nov 6, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Net Interest Income

$98.91KFY 2025
$165.67K0FY 2024FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$98,911reported
FY 20242024-12-31$165,669reported

Pharmaceutical preparations

Mira Pharmaceuticals, Inc. is the 379th largest of the 553 covered companies the SEC files under this code, by market cap. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Mira Pharmaceuticals, Inc. · CIK 1904286 · Engraved from SEC EDGAR